Literature DB >> 17846116

Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Florence Dzierszinski1, Marion Pepper, Jason S Stumhofer, David F LaRosa, Emma H Wilson, Laurence A Turka, Sandra K Halonen, Christopher A Hunter, David S Roos.   

Abstract

Challenge with the intracellular protozoan parasite Toxoplasma gondii induces a potent CD8+ T-cell response that is required for resistance to infection, but many questions remain about the factors that regulate the presentation of major histocompatibility complex class I (MHC-I)-restricted parasite antigens and about the role of professional and nonprofessional accessory cells. In order to address these issues, transgenic parasites expressing ovalbumin (OVA), reagents that track OVA/MHC-I presentation, and OVA-specific CD8+ T cells were exploited to compare the abilities of different infected cell types to stimulate CD8+ T cells and to define the factors that contribute to antigen processing. These studies reveal that a variety of infected cell types, including hematopoietic and nonhematopoietic cells, are capable of activating an OVA-specific CD8+ T-cell hybridoma, and that this phenomenon is dependent on the transporter associated with antigen processing and requires live T. gondii. Several experimental approaches indicate that T-cell activation is a consequence of direct presentation by infected host cells rather than cross-presentation. Surprisingly, nonprofessional antigen-presenting cells (APCs) were at least as efficient as dendritic cells at activating this MHC-I-restricted response. Studies to assess whether these cells are involved in initiation of the CD8+ T-cell response to T. gondii in vivo show that chimeric mice expressing MHC-I only in nonhematopoietic compartments are able to activate OVA-specific CD8+ T cells upon challenge. These findings associate nonprofessional APCs with the initial activation of CD8+ T cells during toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846116      PMCID: PMC2168266          DOI: 10.1128/IAI.00954-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

Review 1.  Toxoplasma gondii and MHC-restricted antigen presentation: on degradation, transport and modulation.

Authors:  C G Lüder; F Seeber
Journal:  Int J Parasitol       Date:  2001-10       Impact factor: 3.981

2.  Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.

Authors:  G Arrode; C Boccaccio; J Lulé; S Allart; N Moinard; J P Abastado; A Alam; C Davrinche
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Authors:  G A Taylor; C M Collazo; G S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; E A Southon; S W Reid; L Tessarollo; M Bray; D W McVicar; K L Komschlies; H A Young; C A Biron; A Sher; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue.

Authors:  J P J Saeij; S Coller; J P Boyle; M E Jerome; M W White; J C Boothroyd
Journal:  Nature       Date:  2006-12-20       Impact factor: 49.962

5.  Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.

Authors:  C Pope; S K Kim; A Marzo; D Masopust; K Williams; J Jiang; H Shen; L Lefrançois
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

Authors:  T M Kündig; M F Bachmann; C DiPaolo; J J Simard; M Battegay; H Lother; A Gessner; K Kühlcke; P S Ohashi; H Hengartner
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

7.  Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP.

Authors:  S K Halonen; G A Taylor; L M Weiss
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 8.  Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.

Authors:  U Yrlid; M Svensson; C Johansson; M J Wick
Journal:  FEMS Immunol Med Microbiol       Date:  2000-04

9.  Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.

Authors:  L J Sigal; K L Rock
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.

Authors:  L L Lenz; E A Butz; M J Bevan
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

View more
  40 in total

1.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

2.  Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.

Authors:  Nicolas Blanchard; Federico Gonzalez; Marie Schaeffer; Nathalie T Joncker; Tiffany Cheng; Anjali J Shastri; Ellen A Robey; Nilabh Shastri
Journal:  Nat Immunol       Date:  2008-06-29       Impact factor: 25.606

Review 3.  Nucleic acid transfection and transgenesis in parasitic nematodes.

Authors:  James B Lok
Journal:  Parasitology       Date:  2011-08-31       Impact factor: 3.234

Review 4.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

5.  Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.

Authors:  Jason R Baird; Katelyn T Byrne; Patrick H Lizotte; Seiko Toraya-Brown; Uciane K Scarlett; Matthew P Alexander; Mee Rie Sheen; Barbara A Fox; David J Bzik; Marcus Bosenberg; David W Mullins; Mary Jo Turk; Steven Fiering
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

6.  Genetic identification of essential indels and domains in carbamoyl phosphate synthetase II of Toxoplasma gondii.

Authors:  Barbara A Fox; Jessica G Ristuccia; David J Bzik
Journal:  Int J Parasitol       Date:  2008-10-21       Impact factor: 3.981

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 8.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

9.  Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii.

Authors:  Beena John; Tajie H Harris; Elia D Tait; Emma H Wilson; Beth Gregg; Lai Guan Ng; Paulus Mrass; David S Roos; Florence Dzierszinski; Wolfgang Weninger; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

10.  Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells.

Authors:  Romina S Goldszmid; Isabelle Coppens; Avital Lev; Pat Caspar; Ira Mellman; Alan Sher
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.